APH vs NVDA

Amphenol Corporation exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust fundamentals. The company delivers exceptional profitability metrics, including a 34.81% ROE and 27.48% operating margin, alongside explosive year-over-year revenue and earnings growth. However, the stock trades at a steep valuation (P/E of 50.84 vs. sector average of 89.67) and shows bearish insider activity, with $140.28M in net insider selling over the past six months. While growth and profitability are compelling, elevated multiples and insider selling temper immediate upside potential.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.